GB1455997A - M-dioxane-5-methylamine analgesics - Google Patents

M-dioxane-5-methylamine analgesics

Info

Publication number
GB1455997A
GB1455997A GB5711373A GB5711373A GB1455997A GB 1455997 A GB1455997 A GB 1455997A GB 5711373 A GB5711373 A GB 5711373A GB 5711373 A GB5711373 A GB 5711373A GB 1455997 A GB1455997 A GB 1455997A
Authority
GB
United Kingdom
Prior art keywords
formula
image
analgesics
methylamine
dioxane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5711373A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of GB1455997A publication Critical patent/GB1455997A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Abstract

The m-dioxanes correspond to the formula I <IMAGE> the meanings of the symbols being given in Patent Claim 1. The compounds, as well as those which have been partially demethylated at the amine nitrogen, exhibit an excellent analgesic action without producing addiction in the treated patient. The compounds are prepared by reacting a ketone of the formula II <IMAGE> with an amine of the formula <IMAGE> and reducing the resulting enamine catalytically in the presence of hydrogen to give a compound of the formula I.
GB5711373A 1972-12-08 1973-12-10 M-dioxane-5-methylamine analgesics Expired GB1455997A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31322172A 1972-12-08 1972-12-08

Publications (1)

Publication Number Publication Date
GB1455997A true GB1455997A (en) 1976-11-17

Family

ID=23214841

Family Applications (2)

Application Number Title Priority Date Filing Date
GB5711373A Expired GB1455997A (en) 1972-12-08 1973-12-10 M-dioxane-5-methylamine analgesics
GB2900376A Expired GB1455998A (en) 1972-12-08 1973-12-10 2-alpha-substituted-amino-benzyl-1,3-propane-diols

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB2900376A Expired GB1455998A (en) 1972-12-08 1973-12-10 2-alpha-substituted-amino-benzyl-1,3-propane-diols

Country Status (27)

Country Link
JP (2) JPS5734835B2 (en)
AR (3) AR206306A1 (en)
AT (2) AT332396B (en)
BE (1) BE808340A (en)
BG (4) BG21223A3 (en)
CA (2) CA1014560A (en)
CH (4) CH605903A5 (en)
CS (3) CS193480B2 (en)
CY (1) CY1017A (en)
DD (3) DD115653A5 (en)
DE (1) DE2361340C2 (en)
DK (1) DK134717B (en)
ES (4) ES421291A1 (en)
FR (1) FR2209578B1 (en)
GB (2) GB1455997A (en)
HK (1) HK60479A (en)
HU (2) HU168620B (en)
IE (1) IE40226B1 (en)
IL (1) IL43773A (en)
KE (1) KE2976A (en)
MY (1) MY8000064A (en)
NL (1) NL7316839A (en)
PH (2) PH15197A (en)
SE (3) SE403377B (en)
SU (4) SU578001A3 (en)
YU (3) YU35447B (en)
ZA (1) ZA739207B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9376409B2 (en) * 2012-05-09 2016-06-28 Boehringer Ingelheim International Gmbh Methods for making oxetan-3-ylmethanamines
LV14983B (en) * 2013-10-15 2015-06-20 Olainfarm, A/S Method for producing intermediates of phenibut

Also Published As

Publication number Publication date
BE808340A (en) 1974-06-07
SU663305A3 (en) 1979-05-15
BG21409A3 (en) 1976-05-20
CA1024150A (en) 1978-01-10
YU36171B (en) 1982-02-25
CS222209B2 (en) 1983-05-27
DK134717B (en) 1977-01-03
DE2361340A1 (en) 1974-06-12
BG26205A4 (en) 1979-02-15
JPS4987680A (en) 1974-08-22
SE428378B (en) 1983-06-27
DD110864A5 (en) 1975-01-12
ATA1026073A (en) 1975-10-15
BG22386A3 (en) 1977-02-20
SE417196B (en) 1981-03-02
SE7701795L (en) 1977-02-17
CS193480B2 (en) 1979-10-31
IL43773A0 (en) 1974-03-14
NL7316839A (en) 1974-06-11
JPS4987681A (en) 1974-08-22
YU318573A (en) 1981-06-30
HU168620B (en) 1976-06-28
YU318473A (en) 1980-09-25
YU35447B (en) 1981-02-28
FR2209578B1 (en) 1977-09-02
FR2209578A1 (en) 1974-07-05
HK60479A (en) 1979-08-31
DD109625A5 (en) 1974-11-12
MY8000064A (en) 1980-12-31
AT330773B (en) 1976-07-26
YU109380A (en) 1981-04-30
BG21223A3 (en) 1976-03-20
SE7701796L (en) 1977-02-17
SE403377B (en) 1978-08-14
CH614439A5 (en) 1979-11-30
AT332396B (en) 1976-09-27
SU587861A3 (en) 1978-01-05
CH605903A5 (en) 1978-10-13
ES444911A1 (en) 1977-09-01
ES421291A1 (en) 1976-07-01
HU168763B (en) 1976-07-28
IL43773A (en) 1979-05-31
YU36020B (en) 1981-11-13
IE40226B1 (en) 1979-04-11
KE2976A (en) 1979-07-20
CH619219A5 (en) 1980-09-15
AR206306A1 (en) 1976-07-15
CY1017A (en) 1979-11-23
JPS5734835B2 (en) 1982-07-26
ES421290A1 (en) 1976-07-01
ZA739207B (en) 1975-07-30
CA1014560A (en) 1977-07-26
ATA1026173A (en) 1976-01-15
GB1455998A (en) 1976-11-17
SU578001A3 (en) 1977-10-25
JPS5742633B2 (en) 1982-09-09
AR212416A1 (en) 1978-07-14
DE2361340C2 (en) 1983-11-24
CH630914A5 (en) 1982-07-15
AU6321773A (en) 1975-06-05
CS222208B2 (en) 1983-05-27
AR212012A1 (en) 1978-04-28
DK134717C (en) 1977-05-31
IE40226L (en) 1974-06-08
PH15197A (en) 1982-09-17
SU648081A3 (en) 1979-02-15
ES444716A1 (en) 1977-05-16
PH14923A (en) 1982-01-29
DD115653A5 (en) 1975-10-12

Similar Documents

Publication Publication Date Title
ES450536A1 (en) Chroman-4-ones and process for preparing same
ES447011A1 (en) Anti-diarrheal compounds
GB1455997A (en) M-dioxane-5-methylamine analgesics
ES8302733A1 (en) Novel anthracycline derivative, process for production thereof, and pharmaceutical composition comprising said compound.
ES415241A1 (en) 4-(4)-biphenylyl)-1-butanol
GB1494823A (en) Process for the production of 2-aryl-2h-benzotriazoles
FR2661176B1 (en) NEW PROCESS FOR THE PREPARATION OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE IN REDUCTIVE AMINATION.
ES447664A1 (en) Cardenolide derivatives
ES458957A1 (en) 1-aryloxy-2 - hydroxy - 3 - aminopropanes and process for their preparation
ES414956A1 (en) Halogenated 4-(4&#39;-bisphenylyl)-butanols
JPS5655382A (en) Manufacture of ciss2*66dimethylmorpholine
FR2362129A1 (en) 9-HYDROXYHEXAHYDROBENZO (C) QUINOLEINS AND SYNTHESIS INTERMEDIARIES
GB1387512A (en) Method for the preparation of hydrogen peroxide
GB1436377A (en) Isoquinoline derivatives
CH612671A5 (en) Process for producing new ethers
CS182226B2 (en) Process for preparing solution of polyisoprene based on linear cis 1,4-polyisoprene
ES388822A1 (en) Biocidal composition and disinfecting method
JPS52718A (en) Process for producing magnets containing rare earth elements
CH609049A5 (en) Process for the preparation of 2-aminoimidazoles
ES455870A1 (en) Diarylacetamidopropanes processes for producing them and compositions containing them
ES409555A1 (en) A procedure for the obtaining of new derivatives of cefalosporine. (Machine-translation by Google Translate, not legally binding)
FR2318149B1 (en)
ES392785A1 (en) Process for the manufacture of a pyroglutamylpeptide
CH612907A5 (en) Process for the preparation of a new 1-aryloxy-4-amino-2-butanol
ES428011A1 (en) Procedure for the preparation of 2-amino-3,5-dibromobencilamina. (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
429A Application made for amendment of specification (sect. 29/1949)
429H Application (made) for amendment of specification now open to opposition (sect. 29/1949)
429D Case decided by the comptroller ** specification amended (sect. 29/1949)
SPA Amended specification published
PCNP Patent ceased through non-payment of renewal fee